Understanding how cytochrome P450 enzymes are regulated
Structural regulation of Class-I and Class-II cytochrome P450 enzymes
This study is looking at how certain enzymes in your body, which help break down cholesterol and medications, work and how their activity can change based on different conditions, with the hope that this will lead to better treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project ID | NIH-11010663 on NIH RePORTER |
What this research studies
This research investigates the structural regulation of cytochrome P450 enzymes, which play a crucial role in various biological processes such as cholesterol metabolism and drug metabolism. The project aims to explore how the interaction between these enzymes and their substrates, as well as their redox partner proteins, can influence their function. By employing biochemical and biophysical methods, the research will delve into the mechanisms of enzyme regulation and how these processes can be affected by different factors, including pH and drug interactions. Patients may benefit from insights gained into how these enzymes work, potentially leading to improved drug therapies and metabolic health.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with metabolic disorders or those affected by drug metabolism issues.
Not a fit: Patients with conditions unrelated to cholesterol metabolism or drug interactions may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment of conditions related to cholesterol metabolism and drug interactions.
How similar studies have performed: Previous research has shown promising results in understanding cytochrome P450 enzymes, indicating that this approach has potential for significant advancements.
Where this research is happening
Amherst, United States
- State University of New York at Buffalo — Amherst, United States (Active)
Researchers
- Principal investigator: Estrada, David Fernando — State University of New York at Buffalo
- Study coordinator: Estrada, David Fernando
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.